FDA Investigator Alexis O Robinson
Alexis O Robinson has conducted inspections on 102 sites in 2 countries as of 28 Aug 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
102
Last Inspection Date:
28 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Korea (Republic of)
FDA Investigators that have inspected at least one site in common with Alexis O Robinson:
Alan Escalona,
Alantis N Griffin,
Andre L Duhon,
Asad Ali,
Barbara S Manson,
Carmen M Chan,
Catherine D Djordjevic,
Charles N Dupont,
Charvais S Bogan,
Charvais S Hill,
Christian L Witkovskie,
Christopher N Dedeaux,
Claire M Minden,
Combs,
Craig P Seaborn,
Dana M Klimavicz,
Daniel L Aisen,
Daphne A Videau,
David J Leray,
David R Heiar,
Dawn P Hall,
Debra A Sherman,
Diana M Guidry,
Diane S Douglas,
Donna D Gallien, MPH,
Edward A Brunt,
Elizabeth D Connell,
Eric R Holm,
Evan M Kupper,
Francis A Guidry,
Gloria J Horner,
Grant D Jones,
Herbert M Corbello,
Herman S Clincy,
Jacquelyn Bradford,
Jennifer A Downie,
Jennifer A Pruden,
Jerry T Hunt,
Jose R Hernandez,
Joseph W Morin,
Justin N Henson,
Kate E Jesse,
Kena M Senegal,
Kerry Ann Latham,
Kip J Hanks,
Krista W Whitten,
Lakisha N Morton,
Larry A Estavan,
Lawrence A Butler,
Leisha R Shipes,
Lindsay H Bertling,
Llopis,
Mahaffey,
Marcia G Evans,
Marcus A Green,
Margaret E Slimbach,
Natalie A Guidry,
Nicole D Lyons,
Patrick C Dooley,
Richard L Licari,
Samuel L Collins,
Sandricka M Mosley,
Scott A Watson,
Shanna R Haden,
Shelton L Stribling,
Shirhonda D Thorn,
Shymetris M Allen,
Sidney M Smith,
Talmane J Fisher,
Tammy M Phillips,
Thomas B Smith,
Thomas O Morgan,
Tomeka A Miller,
Toni M Booker,
Traci M Armand,
Verlinda A Narcisse,
Wanda B Coats,
Wayne S Fortenberry,
Wendy R Blame
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more